CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,975,156
- in 10 filings, $2.0M under 10b5-1 plans
Net −$1,975,156. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-05 | Pera Antonio R Director | Grant or award · Stock Option (right to buy) | +16,024 | 16,024 | ||
| 2020-08-05 | Thoma Jeanne Director | Grant or award | +7,421 | 7,421 | ||
| 2020-08-05 | Thoma Jeanne Director | Grant or award · Stock Option (right to buy) | +16,024 | 16,024 | ||
| 2020-05-11 | Walsh Patrick D Interim President and CEO | Grant or award | +7,050 | 20,096 | ||
| 2020-04-10 | HAUGHEY THOMAS Director | Grant or award | +7,119 | 18,410 | ||
| 2020-04-10 | Brown Robert E. JR Director | Grant or award | +7,119 | 29,680 | ||
| 2020-04-10 | NASH DAVID Director | Grant or award | +7,119 | 12,355 | ||
| 2020-04-10 | Walsh Patrick D Director | Grant or award | +9,255 | 13,046 | ||
| 2020-04-10 | CAREY STEPHEN P. Vice President and CFO | Grant or award | +39,767 | 63,145 | ||
| 2020-04-10 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Grant or award | +39,767 | 93,043 | ||
| 2020-04-10 | Marken James G. SVP Ops & Prod Dev | Grant or award | +24,548 | 85,297 | ||
| 2020-04-07 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Shares withheld for taxes | −396 | $43.93 | $17K | 53,276 |
| 2020-04-07 | PRZYBYL ARTHUR President and CEO | Shares withheld for taxes | −2,115 | $43.93 | $93K | 190,309 |
| 2020-04-07 | Marken James G. SVP Ops & Prod Dev | Shares withheld for taxes | −144 | $43.93 | $6K | 60,749 |
| 2020-04-06 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Shares withheld for taxes | −666 | $43.22 | $29K | 53,672 |
| 2020-04-06 | PRZYBYL ARTHUR President and CEO | Shares withheld for taxes | −3,282 | $43.22 | $142K | 192,424 |
| 2020-04-06 | Marken James G. SVP Ops & Prod Dev | Shares withheld for taxes | −337 | $43.22 | $15K | 60,893 |
| 2020-04-06 | CAREY STEPHEN P. Vice President and CFO | Shares withheld for taxes | −612 | $43.22 | $26K | 23,378 |
| 2020-03-31 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Shares withheld for taxes | −552 | $40.74 | $22K | 54,338 |
| 2020-03-31 | CAREY STEPHEN P. Vice President and CFO | Shares withheld for taxes | −507 | $40.74 | $21K | 23,990 |
Page 26 of 31 · 601 trades